Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

Capsule: SOP for Screening Polymers for Capsule Coating – V 2.0

Posted on By

Capsule: SOP for Screening Polymers for Capsule Coating – V 2.0

Standard Operating Procedure for Screening Polymers for Capsule Coating

Department Capsule Manufacturing
SOP No. SOP/CM/024/2025
Supersedes SOP/CM/024/2022
Page No. Page 1 of 6
Issue Date 01/02/2025
Effective Date 05/02/2025
Review Date 01/02/2026

1. Purpose

The purpose of this SOP is to outline the procedure for screening and selecting polymers suitable for capsule coating to ensure optimal capsule performance, including controlled release, stability, and protection of the active pharmaceutical ingredient (API).

2. Scope

This SOP applies to the screening of all polymers used in capsule coating formulations, including polymers for immediate release, controlled release, and enteric coatings.

3. Responsibilities

  • Formulation Development Team: Responsible for screening, testing, and selecting appropriate polymers for capsule coating based on performance criteria.
  • Quality Control (QC) Team: Ensures that the selected polymers meet the required standards for quality, consistency, and performance in capsule coatings.
  • Quality Assurance (QA) Team: Oversees compliance with SOPs and regulatory requirements during polymer screening and selection processes.
  • Procurement Team: Responsible for sourcing the selected polymers from approved suppliers and ensuring their availability for the formulation process.

4. Accountability

The Formulation Development Supervisor is accountable for ensuring the proper screening and selection of polymers for capsule

coatings, while the QA Manager is responsible for ensuring compliance with regulatory guidelines and internal quality standards.

5. Procedure

5.1 Identifying Requirements for Coating

Ensure that the functional requirements for the capsule coating are clearly defined:

  1. Coating Functionality

    1. Determine the primary function of the coating (e.g., immediate release, delayed release, or controlled release).
    2. Consider the stability, protection, and aesthetic requirements of the coating, such as color, gloss, and texture.
  2. API Compatibility

    1. Assess the compatibility of the API with the polymer options to ensure that no degradation, interaction, or instability occurs during the coating process.
See also  Capsule: SOP for Identification Testing of Capsule Fill Materials - V 2.0

5.2 Selecting Suitable Polymers

Screen and select polymers based on the defined coating requirements:

  1. Polymer Types

    1. Choose polymers based on their release characteristics, such as natural and synthetic polymers for different types of coating (e.g., HPMC for controlled release, Eudragit for enteric coatings).
    2. Consider the polymer’s solubility in water, pH sensitivity, and ability to form a uniform coating film on the capsule.
  2. Polymer Functional Properties

    1. Assess the properties of the polymer such as viscosity, film-forming capability, and ability to protect the API from moisture or light.
    2. Consider the ease of application, including sprayability and the drying process of the polymer when used in coating equipment.

5.3 Conducting Polymer Testing

Test selected polymers for performance and compatibility with capsule formulations:

  1. Film Formation Test

    1. Test the polymer’s ability to form a smooth and uniform coating on the capsule using a film-forming test.
    2. Evaluate the appearance, smoothness, and uniformity of the coating under visual inspection and microscopy.
  2. Dissolution Testing

    1. Conduct dissolution tests on capsules coated with the selected polymers to evaluate the release profile of the API.
    2. Monitor the release rate and compare the results against the desired specifications for immediate or controlled release.
  3. Stability Testing

    1. Conduct accelerated and long-term stability testing on the coated capsules to assess the effect of the coating on the stability of the API under various storage conditions (temperature, humidity, etc.).
    2. Ensure that the polymer maintains the integrity of the capsule coating during the shelf life of the product.
  4. Compatibility Study

    1. Perform compatibility studies between the polymer and excipients used in the capsule fill to ensure there are no adverse interactions or instability in the final product.
See also  Capsule: SOP for Process Validation of Capsule Filling Operations - V 2.0

5.4 Optimizing Polymer Formulation

Optimize the formulation of the polymer coating based on the testing results:

  1. Polymer Concentration

    1. Adjust the concentration of the selected polymer to achieve the desired coating thickness and performance.
    2. Ensure that the polymer solution or dispersion is uniform and free of particles that could affect the application process.
  2. Plasticizer Selection

    1. Select appropriate plasticizers to improve the flexibility and workability of the polymer coating, preventing cracking or peeling.
    2. Test different plasticizers to determine the optimal combination for a flexible and durable coating.
  3. Coating Process Parameters

    1. Optimize the coating process parameters such as spray rate, drying temperature, and spray distance to ensure consistent coating quality.
    2. Ensure that the coating process is scalable for large-scale manufacturing while maintaining product quality.

5.5 Final Evaluation and Selection of Polymer

Evaluate the final selection of the polymer based on all testing results:

  1. Final Testing

    1. Conduct final dissolution and stability tests on the polymer-coated capsules to ensure that the formulation meets all quality specifications for release and stability.
    2. Confirm that the coating provides the required functionality such as controlled release or enteric protection.
  2. Polymer Approval

    1. Approve the selected polymer based on the results of all testing and evaluation, ensuring it meets regulatory standards and performance specifications.

5.6 Documentation and Record-Keeping

Ensure proper documentation of the polymer screening and selection process:

  1. Documentation of Polymer Selection

    1. Document all polymer screening, testing, and evaluation results in a detailed report that includes the selected polymer, the testing methods used, and the final recommendations.
    2. Ensure that all documentation is reviewed and signed off by the formulation team and the QA team.
  2. Record Retention

    1. Ensure that all records, including test data, approval forms, and any deviations, are securely stored for future reference and regulatory audits.
See also  Capsule: SOP for Operating Capsule Inspection Machines - V 2.0

6. Abbreviations

  • SOP: Standard Operating Procedure
  • API: Active Pharmaceutical Ingredient
  • QA: Quality Assurance
  • QC: Quality Control
  • GMP: Good Manufacturing Practice
  • HPLC: High-Performance Liquid Chromatography
  • FTIR: Fourier Transform Infrared Spectroscopy
  • DSC: Differential Scanning Calorimetry

7. Documents

  1. Polymer Screening Report (Annexure-1)
  2. Polymer Compatibility Study (Annexure-2)
  3. Polymer Coating Test Results (Annexure-3)

8. References

  • USP <711> – Dissolution Testing
  • ICH Q1A (R2) – Stability Testing of New Drug Substances and Products
  • FDA Guidance for Industry: Capsule Coating

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Polymer Screening Report

Date Polymer Name Study Type Result
03/02/2025 Polymer-123 Compatibility Test Stable with API

Annexure-2: Polymer Compatibility Study

Polymer-123

css
Copy

Date Polymer API Test Method Outcome
04/02/2025 API-456 DSC No incompatibility

Annexure-3: Polymer Coating Test Results

Date Test Type Result Action Taken
05/02/2025 Dissolution Test Pass Formulation approved

Revision History:

Revision Date Revision No. Revision Details Reason for Revision Approved By
01/01/2024 1.0 Initial Version New SOP Creation QA Head
01/02/2025 2.0 Updated polymer selection process Standardization QA Head
Capsules V 2.0 Tags:Active pharmaceutical ingredients (APIs) Capsule excipients, Capsule batch records, Capsule cleaning procedures, Capsule content uniformity, Capsule deviation management, Capsule disintegration testing, Capsule dissolution testing, Capsule filling process, Capsule inspection techniques, Capsule labeling requirements, Capsule maintenance protocols, Capsule Manufacturing, Capsule manufacturing equipment, Capsule packaging standards, Capsule process validation, Capsule production scheduling, Capsule Quality Control, Capsule regulatory compliance, Capsule safety guidelines, Capsule sealing methods, Capsule size specifications, Capsule stability testing, Capsule storage conditions, Capsule training programs, Empty capsule shells, Hard gelatin capsules, Pharmaceutical capsules, Soft gelatin capsules, Vegetarian capsules

Post navigation

Previous Post: SOP for Ensuring Proper Documentation and Traceability in Quarantine Area – V 2.0
Next Post: Job Safety Analysis for Vibration Feeder

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version